Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

Over the past few decades, treatment of multidrug-resistant (MDR)/extensively drug-resistant (XDR) tuberculosis (TB) has been challenging because of its prolonged duration (up to 20–24 months), toxicity, costs and sub-optimal outcomes. After over 40 years of neglect, two new drugs (bedaquiline and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pontali, Emanuele, Raviglione, Mario C., Migliori, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489134/
https://www.ncbi.nlm.nih.gov/pubmed/31142549
http://dx.doi.org/10.1183/16000617.0035-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489134/
https://www.ncbi.nlm.nih.gov/pubmed/31142549
http://dx.doi.org/10.1183/16000617.0035-2019

Ejemplares similares